Member Content

Small Cap Profile: Biodesix (BDSX) a Growth Small Cap with a Massive Opportunity in Lung Cancer Testing

by Joe Kunkle | Jan 17, 2021

Biodesix is a newer issue that has seen shares rise 41.5% YTD as the diagnostics sector is seeing a lot of attention with expectations for healthcare reform.

BDSX is a leading data-driven diagnostic solutions company leveraging state of the art te...

Please login to continue reading this article.

Options Hawk Max

$300 | 30 days

Options Hawk Trading Hub Live Chat
Hawk’s Market Blitz
Spotlight Trades (2 Per Week)
Market Recap
Weekly Earnings Snapshots
Live Mock Portfolio
1 on 1 Access
Hawk’s Trader Toolbox
Street Research
OptionsHawk Research
Daily Options Radar
OptionHawk’s Weekly Radar Report
Options Hawk Market Outlook Access
Daily Earnings Grid
Weekly and Monthly OpEx Sheets
Notable Options Database
OptionsHawk Quarterly Market Brief

More About this Plan

Options Hawk Elite

$149 | 30 days

Hawk’s Market Blitz
Spotlight Trades (2 Per Week)
Market Recap
Weekly Earnings Snapshots
OptionsHawk Research
Daily Options Radar
OptionHawk’s Weekly Radar Report
Options Hawk Market Outlook Access
Daily Earnings Grid
OptionsHawk Quarterly Market Brief

More About this Plan